MONOPAR THERAPEUTICS INC (MNPR)
US61023L1089 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -7.62M | -8.40M | -10.52M | -9.10M | -6.30M | |||
| Change In Working Capital | -1.39M | -1.35M | 1.65M | 320.00K | 440.00K | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | -10.00K | |||
| Other non cash items | 1.75M | 1.90M | 1.64M | 1.47M | 1.20M | |||
| OPERATING CASH FLOW | -7.24M | -7.86M | -7.23M | -7.32M | -4.66M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | 4.92M | 4.93M | -4.92M | N/A | N/A | |||
| INVESTING CASH FLOW | 4.92M | 4.93M | -4.92M | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 120.00K | |||
| Stock Issued/Repurchased | 4.45M | 2.07M | 110.00K | 10.94M | 8.18M | |||
| Other Financing Activity | -37.71K | -46.97K | -80.00K | -60.00K | -120.00K | |||
| FINANCING CASH FLOW | 4.41M | 2.03M | 30.00K | 10.88M | 8.18M | |||
| Exchange Rate Effect | -8.45K | -16.80K | 0.00 | 0.00 | 0.00 | |||
| CHANGE IN CASH | 2.08M | -920.11K | -12.12M | 3.57M | 3.52M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.24M | -7.86M | -7.23M | -7.32M | -4.66M | |||
| FREE CASH FLOW | -7.24M | -7.86M | -7.23M | -7.32M | -4.66M | |||
All data in USD